Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Roche”

A Safety and Efficacy Trial of a Combination of Bendamustine, Rituximab and Lenalidomide in Patients With Chronic Lymphocytic LeukemiaCompleted
NCT01558167Phase 1, Phase 2Updated May 15, 2018
Sponsor: German CLL Study Group
Chronic Lymphocytic Leukemia
Germany
A Study to Investigate the Pharmacokinetics of RO7079901 and Meropenem in Participants With a Complicated Urinary Tract InfectionCompleted
NCT03174795Phase 1Updated May 15, 2018
Sponsor: Hoffmann-La Roche
Urinary Tract Infections
United States, Hungary, Latvia, Poland, Serbia
An Observational Study of Avastin (Bevacizumab) in Elderly Patients With Non-Squamous Non-Small Cell Lung Cancer in Clinical PracticeCompleted
NCT01893268N/AUpdated May 14, 2018
Sponsor: Hoffmann-La Roche
Non-Squamous Non-Small Cell Lung Cancer
France
An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer (ACORN)Completed
NCT01506167N/AUpdated May 14, 2018
Sponsor: Hoffmann-La Roche
Colorectal Cancer
United Kingdom
An Observational Study to Evaluate the Clinical Effectiveness, Quality of Life, Safety and Tolerability of Tocilizumab (TCZ) in Patients With Rheumatoid Arthritis (RA) in Daily Clinical PracticeCompleted
NCT02552940N/AUpdated May 11, 2018
Sponsor: Hoffmann-La Roche
Rheumatoid Arthritis
Belgium, Luxembourg
A Study to Evaluate the Efficacy and Safety of Vismodegib in Combination With Ruxolitinib for the Treatment of Intermediate- or High-Risk Myelofibrosis (MF)Completed
NCT02593760Phase 1Updated May 11, 2018
Sponsor: Hoffmann-La Roche
Myelofibrosis
United States, Canada, Germany, Italy
U-Act-After: An Observational Study on Long-Term Efficacy of Tight Control RoActemra/Actemra (Tocilizumab) and/or Methotrexate in Patients With Early Rheumatoid Arthritis Who Have Participated in the U-Act-Early Study (ML22497)Completed
NCT01918267N/AUpdated May 11, 2018
Sponsor: Hoffmann-La Roche
Rheumatoid Arthritis
Netherlands
International Diabetes Closed Loop (iDCL) Trial: Research Site Training ProtocolCompleted
NCT02844517NAUpdated May 7, 2018
Sponsor: University of Virginia
Diabetes Mellitus, Type 1
United States, France, Italy, Netherlands
A Comparison of Continuous Bevacizumab (Avastin) Treatment or Placebo in Addition to Lomustine Followed by Standard of Care After Disease Progression in Participants With GlioblastomaCompleted
NCT01860638Phase 2Updated Apr 30, 2018
Sponsor: Hoffmann-La Roche
Glioblastoma
Austria, Bulgaria, Canada, Croatia, Estonia +10 more
A Single-Arm Study to Evaluate Administration of Lebrikizumab by Participants or Caregivers in the Home SettingWithdrawn
NCT02546869Phase 3Updated Apr 25, 2018
Sponsor: Hoffmann-La Roche
Asthma
Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder CancerCompleted
NCT00142480Phase 2Updated Apr 25, 2018
Sponsor: Massachusetts General Hospital
Biliary Tract Cancer · Gallbladder Adenocarcinoma
United States
Vascular Events In Noncardiac Surgery Patients Cohort Evaluation Study (VISION)Completed
NCT00512109N/AUpdated Apr 24, 2018
Sponsor: McMaster University
Vascular Death · Myocardial Infarction · Cardiac Arrest · Stroke
Brazil, Canada, China, Colombia, India +2 more
A Study to Investigate the Intrapulmonary Lung Penetration of Nacubactam in Healthy ParticipantsCompleted
NCT03182504Phase 1Updated Apr 23, 2018
Sponsor: Hoffmann-La Roche
Gram-negative Bacterial Infections
United States
A Study of MabThera/Rituxan (Rituximab) in Combination With Fludarabine And Cyclophosphamide as Primary Therapy in Elderly Patients With Chronic Lymphocytic LeukemiaCompleted
NCT01263704Phase 2Updated Apr 23, 2018
Sponsor: Hoffmann-La Roche
Lymphocytic Leukemia, Chronic
Israel
A Therapeutic Open Label Study of Tocilizumab in the Treatment of Pulmonary Arterial HypertensionCompleted
NCT02676947Phase 2Updated Apr 19, 2018
Sponsor: Papworth Hospital NHS Foundation Trust
Pulmonary Arterial Hypertension
United Kingdom
A Study of Subcutaneous (SC) Tocilizumab (RoActemra/Actemra) in Participants With Active Rheumatoid Arthritis (RA) and Inadequate Response to Disease-Modifying Anti-Rheumatic Drugs (DMARDs)Completed
NCT02046616Phase 3Updated Apr 13, 2018
Sponsor: Hoffmann-La Roche
Rheumatoid Arthritis
Denmark, Finland, Norway, Sweden
Retrospective Data Collection: Post Study Treatment Anticancer Therapy From IMELDA MO22223Completed
NCT02383576N/AUpdated Apr 13, 2018
Sponsor: Hoffmann-La Roche
Breast Cancer
Brazil, France, India, Italy, Spain +1 more
A Study of Avastin (Bevacizumab) in Patients With Inflammatory or Locally Advanced Breast CancerCompleted
NCT00559845Phase 2Updated Apr 9, 2018
Sponsor: Hoffmann-La Roche
Breast Cancer
Italy
Observational Study Evaluating Rituximab Use and Use of the Patient Alert Card in Participants Receiving Rituximab Infusion for a Non-Oncology Indication at Infusion Centers in EuropeCompleted
NCT02654379N/AUpdated Apr 9, 2018
Sponsor: Hoffmann-La Roche
Off-Label Use
France, Germany, Italy, Spain, United Kingdom
A Study of Atezolizumab in Combination With an Immunotherapy Agent Investigated With or Without Anti-Cd20 Therapy in Patients With Relapsed or Refractory Non-Hodgkin LymphomaWithdrawn
NCT03369964Phase 1Updated Apr 5, 2018
Sponsor: Hoffmann-La Roche
Lymphoma, Non-Hodgkin
United States
A Dose Escalation Study of RO6874813 in Participants With Locally Advanced or Metastatic Solid TumorsCompleted
NCT02558140Phase 1Updated Apr 4, 2018
Sponsor: Hoffmann-La Roche
Neoplasms
United States, France, Spain
PHOENIX Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) and COPEGUS (Ribavirin) Administered After Liver Transplantation for Hepatitis C.Completed
NCT00087633Phase 4Updated Mar 29, 2018
Sponsor: Hoffmann-La Roche
Hepatitis C, Chronic
United States
A Study of Tocilizumab Added to DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to DMARDs.Completed
NCT00996203Phase 4Updated Mar 29, 2018
Sponsor: Hoffmann-La Roche
Rheumatoid Arthritis
Russia
MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal OsteoporosisCompleted
NCT00048061Phase 3Updated Mar 29, 2018
Sponsor: Hoffmann-La Roche
Post Menopausal Osteoporosis
United States, Australia, Belgium, Brazil, Canada +14 more
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal CancerTerminated
NCT00642603Phase 2Updated Mar 29, 2018
Sponsor: Hoffmann-La Roche
Colorectal Cancer
United States

Previous page Next page